Aaron Wealth Advisors LLC Has $363,000 Holdings in CME Group Inc. (NASDAQ:CME)

Aaron Wealth Advisors LLC grew its position in CME Group Inc. (NASDAQ:CMEFree Report) by 4.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,564 shares of the financial services provider’s stock after purchasing an additional 66 shares during the quarter. Aaron Wealth Advisors LLC’s holdings in CME Group were worth $363,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in the company. Truvestments Capital LLC acquired a new position in CME Group in the 3rd quarter valued at $26,000. Dunhill Financial LLC grew its stake in shares of CME Group by 188.4% in the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 81 shares in the last quarter. Fortitude Family Office LLC increased its position in CME Group by 120.3% during the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock worth $35,000 after acquiring an additional 83 shares during the period. Thurston Springer Miller Herd & Titak Inc. raised its stake in CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock worth $43,000 after purchasing an additional 74 shares in the last quarter. Finally, Anchor Investment Management LLC boosted its holdings in CME Group by 52.4% in the 3rd quarter. Anchor Investment Management LLC now owns 378 shares of the financial services provider’s stock valued at $83,000 after purchasing an additional 130 shares during the period. Institutional investors own 87.75% of the company’s stock.

Analyst Ratings Changes

CME has been the subject of a number of analyst reports. Oppenheimer lifted their price target on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a research report on Thursday, October 24th. The Goldman Sachs Group upped their target price on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research report on Thursday, October 3rd. Redburn Atlantic downgraded shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price target for the company. in a report on Tuesday, October 8th. Citigroup cut shares of CME Group from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $255.00 to $250.00 in a research note on Monday, January 6th. Finally, Barclays upped their target price on CME Group from $231.00 to $257.00 and gave the stock an “equal weight” rating in a research note on Monday, December 9th. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $229.27.

Read Our Latest Stock Report on CME Group

CME Group Stock Performance

Shares of CME stock opened at $232.71 on Tuesday. The stock has a market capitalization of $83.86 billion, a PE ratio of 24.47, a PEG ratio of 4.93 and a beta of 0.56. The business’s 50 day simple moving average is $233.29 and its 200 day simple moving average is $220.09. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a one year low of $190.70 and a one year high of $249.02.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period in the prior year, the firm posted $2.25 EPS. The company’s quarterly revenue was up 18.4% on a year-over-year basis. As a group, research analysts forecast that CME Group Inc. will post 10.2 earnings per share for the current year.

CME Group Increases Dividend

The firm also recently disclosed a dividend, which was paid on Thursday, January 16th. Stockholders of record on Friday, December 27th were given a $5.80 dividend. The ex-dividend date was Friday, December 27th. This is a positive change from CME Group’s previous dividend of $2.50. CME Group’s dividend payout ratio (DPR) is 48.37%.

CME Group declared that its board has authorized a share repurchase program on Thursday, December 5th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s board believes its shares are undervalued.

Insider Activity

In other CME Group news, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the completion of the sale, the insider now directly owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. The trade was a 15.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Timothy S. Bitsberger sold 1,000 shares of the stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total transaction of $226,960.00. Following the transaction, the director now directly owns 10,589 shares in the company, valued at $2,403,279.44. This trade represents a 8.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 7,274 shares of company stock valued at $1,648,071 in the last ninety days. 0.30% of the stock is owned by company insiders.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.